IMNM / Immunome, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Immunome, Inc.
US ˙ NasdaqCM ˙ US45257U1088

Deler fremragende 113,249,519 shares
Insideraktier4.731.036 shares
Insider ejerskab4,18 %
Total Insiders20
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

-1 ( )
9526 out of 10986

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

-0.119% ( )
10260 out of 10856

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Immunome, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Richard A Baron Director - [D] 2.343 2.343
Jean Jacques Bienaime Director - [D] 38.415 38.415
Isaac Barchas Director - [D] 2.123.392 2.123.392
Richard F Fitzgerald 7.681
Jack Higgins Chief Scientific Officer - [O] 22.000 22.000
John L Lamattina Director - [D] 66.953 66.953
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Bob Lapetina PAO and VP Finance & Corporate - [O] 12.047 12.047
Robert Lechleider Chief Medical Officer - [O] 15.805 15.805
Michael Lefenfeld Director - [D] 40.747 40.747
I Wistar Iii Morris 10% Owner - [10%] 38.464 38.464
Franklyn G Prendergast Director - [D] 60.840 60.840
Michael Rapp Director - [D] 1.071.172 1.071.172
Max Rosett Chief Financial Officer - [O] 54.037 54.037
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Clay B Siegall President and CEO, Director - [D] [O] 690.704 690.704
Purnanand D Sarma President and CEO, Director - [D] [O] 10.500 10.500
Stoneman Sandra G. Chief Legal Officer & Gen Coun - [O] 5.555 5.555
Philip Tsai Chief Technical Officer - [O] 43.300 43.300
Bruce Turner Chief Strategy Officer - [O] 42.300 42.300
Philip Wagenheim Director - [D] 341.147 341.147
Michael Widlitz Director - [D] 51.315 51.315

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i IMNM / Immunome, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2026-03-27 SIEGALL CLAY B 25.450 19,6700 25.450 19,6700 500.602 21 24.6300 126.232 25,22
2026-03-11 BIENAIME JEAN JACQUES 1.000 21,5500 1.000 21,5500 21.550
2026-03-10 BIENAIME JEAN JACQUES 1.000 22,1200 1.000 22,1200 22.120
2025-12-30 SIEGALL CLAY B 4.729 21,1500 4.729 21,1500 100.018
2025-12-19 SIEGALL CLAY B 7.278 20,4800 7.278 20,4800 149.053
2025-12-19 Tsai Philip 10.000 20,4900 10.000 20,4900 204.900
2025-12-18 SIEGALL CLAY B 46.511 21,5000 46.511 21,5000 999.986
2025-06-03 BIENAIME JEAN JACQUES 5.000 9,3800 5.000 9,3800 46.900
2025-03-26 SIEGALL CLAY B 137.100 7,2900 137.100 7,2900 999.459

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

IMNM / Immunome, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i IMNM / Immunome, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2026-03-23 WAGENHEIM PHILIP 28.200 20,6500 28.200 20,6500 582.330 7 19.3000 -38.070 -6,54
2026-03-20 WAGENHEIM PHILIP 36.800 20,4700 36.800 20,4700 753.296
2024-09-19 Rosett Max 14.380 16,0100 14.380 16,0100 230.224
2024-08-15 Higgins Jack 3.524 13,9250 3.524 13,9250 49.072

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

IMNM / Immunome, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2026-04-03 2026-04-02 4 Higgins Jack IMNM Common Stock S - Sale D 21,6400 -9.438 -204 22.000
2026-04-03 2026-04-02 4 Rosett Max IMNM Common Stock S - Sale D 22,4800 -1.344 -30 54.037
2026-04-03 2026-04-02 4 Rosett Max IMNM Common Stock S - Sale D 21,9100 -63.656 -1.395 55.381
2026-04-03 2026-04-02 4 Rosett Max IMNM Common Stock M - Exercise D 1,3500 39.713 54 119.037
2026-04-03 2026-04-02 4 Rosett Max IMNM Common Stock M - Exercise D 1,0500 31.848 33 79.324
2026-04-01 2026-03-30 4 Higgins Jack IMNM Common Stock G - Gift D -6.291 31.438
2026-03-31 2026-03-27 4 SIEGALL CLAY B IMNM Common Stock P - Purchase D 19,6700 25.450 501 690.704
2026-03-23 2026-03-23 4 WAGENHEIM PHILIP IMNM Common Stock S - Sale D 20,6500 -28.200 -582 341.147
2026-03-23 2026-03-20 4 WAGENHEIM PHILIP IMNM Common Stock S - Sale D 20,4700 -36.800 -753 369.347
2026-03-12 2026-03-11 4 BIENAIME JEAN JACQUES IMNM Common Stock P - Purchase D 21,5500 1.000 22 38.415
2026-03-12 2026-03-10 4 BIENAIME JEAN JACQUES IMNM Common Stock P - Purchase D 22,1200 1.000 22 37.415
2025-12-30 2025-12-30 4 SIEGALL CLAY B IMNM Common Stock P - Purchase D 21,1500 4.729 100 665.254
2025-12-23 2025-12-22 4 Barchas Isaac IMNM Common Stock S - Sale I 22,3400 -11.251 -251 2.031.181
2025-12-23 2025-12-22 4 Barchas Isaac See footnotes IMNM Common Stock S - Sale I 21,7200 -371.949 -8.079 2.042.432
2025-12-22 2025-12-19 4 Higgins Jack As Custodian for Child 1 IMNM Common Stock G - Gift I 1.000 1.000
2025-12-22 2025-12-19 4 Higgins Jack As Custodian for Child 3 IMNM Common Stock G - Gift I 1.000 1.000
2025-12-22 2025-12-19 4 Higgins Jack IMNM Common Stock G - Gift D -1.000 37.729
2025-12-22 2025-12-19 4 Higgins Jack As Custodian for Child 2 IMNM Common Stock G - Gift I 1.000 1.000
2025-12-22 2025-12-19 4 Higgins Jack IMNM Common Stock G - Gift D -1.000 38.729
2025-12-22 2025-12-19 4 Higgins Jack IMNM Common Stock G - Gift D -1.000 39.729
2025-12-22 2025-12-19 4 SIEGALL CLAY B IMNM Common Stock G - Gift D -200.000 660.525
2025-12-22 2025-12-19 4 SIEGALL CLAY B IMNM Common Stock P - Purchase D 20,4800 7.278 149 860.525
2025-12-22 2025-12-19 4 Tsai Philip IMNM Common Stock P - Purchase D 20,4900 10.000 205 43.300
2025-12-18 2025-12-18 4 SIEGALL CLAY B IMNM Common Stock P - Purchase D 21,5000 46.511 1.000 853.247
2025-09-11 2025-09-10 4 Higgins Jack IMNM Common Stock M - Exercise D 1,3500 22.000 30 40.729
2025-06-03 2025-06-03 4 BIENAIME JEAN JACQUES IMNM Common Stock P - Purchase D 9,3800 5.000 47 36.415
2025-03-28 2025-03-27 4 Higgins Jack IMNM Common Stock M - Exercise D 1,3500 5.200 7 18.729
2025-03-26 2025-03-26 4 SIEGALL CLAY B IMNM Common Stock P - Purchase D 7,2900 137.100 999 806.736
2025-03-26 2025-03-25 4 BIENAIME JEAN JACQUES IMNM Common Stock P - Purchase D 7,7800 7.800 61 31.415
2025-03-25 2025-03-24 4 BIENAIME JEAN JACQUES IMNM Common Stock P - Purchase D 8,2100 7.000 57 23.615
2025-03-25 2025-03-24 4 Tsai Philip IMNM Common Stock P - Purchase D 8,4200 12.300 104 33.300
2025-02-03 2025-01-31 4 SIEGALL CLAY B IMNM Common Stock P - Purchase D 7,7500 150.000 1.162 669.636
2024-11-25 2024-11-22 4 SIEGALL CLAY B IMNM Common Stock P - Purchase D 9,7787 33.943 332 519.636
2024-11-25 2024-11-21 4 SIEGALL CLAY B IMNM Common Stock P - Purchase D 9,5412 66.057 630 485.693
2024-11-25 2024-11-21 4 Lechleider Robert IMNM Common Stock P - Purchase D 9,4780 15.805 150 15.805
2024-11-25 2024-11-21 4 Tsai Philip IMNM Common Stock P - Purchase D 9,4300 21.000 198 21.000
2024-09-20 2024-09-19 4 Rosett Max IMNM Common Stock S - Sale D 16,0100 -14.380 -230 47.476
2024-09-20 2024-09-19 4 Rosett Max IMNM Common Stock M - Exercise D 1,0500 42.000 44 61.856
2024-08-19 2024-08-16 4 BIENAIME JEAN JACQUES IMNM Common Stock P - Purchase D 13,9440 7.000 98 16.615
2024-08-19 2024-08-19 4 Higgins Jack IMNM Common Stock G - Gift D -2.471 13.529
2024-08-19 2024-08-15 4 Higgins Jack IMNM Common Stock S - Sale D 13,9250 -3.524 -49 16.000
2024-08-19 2024-08-15 4 Higgins Jack IMNM Common Stock M - Exercise D 1,3500 19.524 26 19.524
2024-05-22 2024-05-21 4 BIENAIME JEAN JACQUES IMNM Common Stock P - Purchase D 13,5699 2.000 27 9.615
2024-05-21 2024-05-21 4 SIEGALL CLAY B IMNM Common Stock P - Purchase D 13,7784 20.434 282 419.636
2024-05-21 2024-05-20 4 SIEGALL CLAY B IMNM Common Stock P - Purchase D 13,9070 79.566 1.107 399.202
2024-01-04 3 Lapetina Bob IMNM Common Stock D 12.047
2023-11-09 3 BIENAIME JEAN JACQUES IMNM Common Stock D 7.615
2023-10-12 3 Barchas Isaac IMNM Common Stock D 121.680
2023-10-12 3 Barchas Isaac See Footnotes IMNM Common Stock I 2.712.328
2023-10-12 3 Rosett Max IMNM Common Stock D 19.856
2023-10-04 2023-10-02 4 SIEGALL CLAY B IMNM Common Stock P - Purchase D 5,9100 169.204 1.000 319.636
2023-10-04 3 SIEGALL CLAY B IMNM Common Stock D 150.432
2023-10-04 2023-10-02 4 Turner Bruce IMNM Common Stock P - Purchase D 5,9100 42.300 250 42.300
2023-10-04 2023-10-02 4 PRENDERGAST FRANKLYN G IMNM Common Stock A - Award D 60.840 60.840
2023-10-03 2023-10-02 4 RAPP MICHAEL IMNM Common Stock A - Award D 5,9100 253.806 1.500 1.071.172
2023-01-17 2023-01-15 4 Lefenfeld Michael IMNM Common Stock A - Award D 4,0000 13.875 56 40.747
2023-01-17 2023-01-15 4 LAMATTINA JOHN L IMNM Common Stock A - Award D 4,0000 15.125 60 66.953
2023-01-17 2023-01-15 4 RAPP MICHAEL IMNM Common Stock A - Award D 4,0000 17.500 70 817.366
2023-01-17 2023-01-15 4 WAGENHEIM PHILIP IMNM Common Stock A - Award D 4,0000 8.750 35 406.147
2021-09-14 2021-09-13 4 RAPP MICHAEL IMNM Common Stock P - Purchase I 19,9600 25.962 518 208.742
2021-09-13 2021-09-10 4 RAPP MICHAEL IMNM Common Stock P - Purchase I 17,8500 15.500 277 182.780
2021-09-13 2021-09-09 4 RAPP MICHAEL IMNM Common Stock P - Purchase I 18,4600 22.280 411 167.280
2021-09-13 2021-09-09 4 RAPP MICHAEL IMNM Common Stock P - Purchase I 17,4400 8.170 142 145.000
2021-08-20 2021-08-18 4 BARON RICHARD A IMNM Stock Option (Right to Buy) M - Exercise D 11,38 -2.343 5.157
2021-08-20 2021-08-18 4 BARON RICHARD A IMNM Common Stock M - Exercise D 11,3800 2.343 27 2.343
2021-06-21 2021-06-16 4 PRENDERGAST FRANKLYN G IMNM Stock Option (Right to Buy) A - Award D 16,96 7.500 7.500
2021-06-01 2021-05-28 4 WAGENHEIM PHILIP IMNM Stock Option (Right to Buy) A - Award D 20,92 3.750 3.750
2021-06-01 2021-05-28 4 RAPP MICHAEL IMNM Stock Option (Right to Buy) A - Award D 20,92 3.750 3.750
2021-06-01 2021-05-28 4 Lefenfeld Michael IMNM Stock Option (Right to Buy) A - Award D 20,92 3.750 3.750
2021-06-01 2021-05-28 4 BARON RICHARD A IMNM Stock Option (Right to Buy) A - Award D 20,92 3.750 3.750
2021-06-01 2021-05-28 4 LAMATTINA JOHN L IMNM Stock Option (Right to Buy) A - Award D 20,92 3.750 3.750
2021-06-01 2021-05-28 4 Widlitz Michael IMNM Stock Option (Right to Buy) A - Award D 20,92 3.750 3.750
2021-06-01 2021-05-28 4 Roche Corleen M. IMNM Stock Option (Right to Buy) A - Award D 20,92 16.609 16.609
2021-06-01 2021-05-28 4 Stoneman Sandra G. IMNM Stock Option (Right to Buy) A - Award D 20,92 16.609 16.609
2021-06-01 2021-05-28 4 Giesing Dennis H IMNM Stock Option (Right to Buy) A - Award D 20,92 16.609 16.609
2021-06-01 2021-05-28 4 Sarma Purnanand D IMNM Stock Option (Right to Buy) A - Award D 20,92 93.354 93.354
2021-05-26 2021-05-26 4 Lefenfeld Michael IMNM Common Stock P - Purchase D 19,0300 1.335 25 26.872
2021-05-26 2021-05-25 4 Lefenfeld Michael IMNM Common Stock P - Purchase D 18,4400 2.715 50 25.537
2021-05-26 2021-05-24 4 Lefenfeld Michael IMNM Common Stock P - Purchase D 17,8000 600 11 22.822
2021-05-26 2021-05-26 4 RAPP MICHAEL IMNM Common Stock P - Purchase I 18,9400 2.300 44 136.830
2021-05-26 2021-05-25 4 RAPP MICHAEL IMNM Common Stock P - Purchase I 18,3200 19.303 354 134.530
2021-05-26 2021-05-24 4 RAPP MICHAEL IMNM Common Stock P - Purchase I 18,3800 31.895 586 115.227
2021-05-26 2021-05-24 4 WAGENHEIM PHILIP IMNM Common Stock P - Purchase D 18,3500 13.500 248 397.397
2021-05-26 2021-05-25 4 Sarma Purnanand D IMNM Common Stock P - Purchase D 18,4100 10.500 193 10.500
2021-05-26 2021-05-24 4 LAMATTINA JOHN L IMNM Common Stock P - Purchase D 18,5800 5.102 95 51.828
2021-05-26 2021-05-24 4 LAMATTINA JOHN L IMNM Common Stock P - Purchase D 18,4400 338 6 46.726
2021-04-21 2021-04-19 4 Roche Corleen M. IMNM Stock Option (Right to Buy) A - Award D 27,53 125.000 125.000
2021-04-05 3/A Stoneman Sandra G. IMNM Common Stock D 5.555
2021-03-29 2021-03-25 4 Giesing Dennis H IMNM Stock Option (Right to Buy) A - Award D 31,83 125.000 125.000
2020-11-05 2020-11-03 4 Stoneman Sandra G. IMNM Employee Stock Option (Right to Buy) A - Award D 11,38 148.837 148.837
2020-11-05 2020-11-03 4 Widlitz Michael IMNM Stock Option (Right to Buy) A - Award D 11,38 7.500 7.500
2020-11-05 2020-11-03 4 Lefenfeld Michael IMNM Stock Option (Right to Buy) A - Award D 11,38 7.500 7.500
2020-11-05 2020-11-03 4 WAGENHEIM PHILIP IMNM Stock Option (Right to Buy)(1) A - Award D 11,38 7.500 7.500
2020-11-05 2020-11-03 4 LAMATTINA JOHN L IMNM Stock Option (Right to Buy) A - Award D 11,38 7.500 7.500
2020-11-05 2020-11-03 4 BARON RICHARD A IMNM Stock Option (Right to Buy) A - Award D 11,38 7.500 7.500
2020-11-05 2020-11-03 4 RAPP MICHAEL IMNM Stock Option (Right to Buy) A - Award D 11,38 7.500 7.500
2020-10-08 2020-10-06 4 Widlitz Michael IMNM Series A Convertible Preferred Stock C - Conversion D -51.315 0
2020-10-08 2020-10-06 4 Widlitz Michael IMNM Common Stock C - Conversion D 51.315 51.315
2020-10-08 2020-10-06 4 RAPP MICHAEL IMNM Warrant (right to buy) C - Conversion D 9,00 166.666 166.666
2020-10-08 2020-10-06 4 RAPP MICHAEL IMNM Warrant (right to buy) C - Conversion D 9,00 -166.666 0
2020-10-08 2020-10-06 4 RAPP MICHAEL IMNM Series A Convertible Preferred Stock C - Conversion D -555.554 0
2020-10-08 2020-10-06 4 RAPP MICHAEL IMNM Common Stock P - Purchase D 12,0000 83.332 1.000 638.886
2020-10-08 2020-10-06 4 RAPP MICHAEL IMNM Common Stock C - Conversion D 555.554 555.554
2020-10-08 2020-10-06 4 MORRIS I WISTAR III IMNM Warrant (right to buy) C - Conversion D 9,00 111.111 111.111
2020-10-08 2020-10-06 4 MORRIS I WISTAR III IMNM Warrant (right to buy) C - Conversion D 9,00 -111.111 0
2020-10-08 2020-10-06 4 MORRIS I WISTAR III IMNM Series A Convertible Preferred Stock C - Conversion I -38.464 0
2020-10-08 2020-10-06 4 MORRIS I WISTAR III IMNM Series A Convertible Preferred Stock C - Conversion D -882.475 0
2020-10-08 2020-10-06 4 MORRIS I WISTAR III IMNM Common Stock C - Conversion I 38.464 38.464
2020-10-08 2020-10-06 4 MORRIS I WISTAR III IMNM Common Stock C - Conversion D 882.475 882.475
2020-10-08 2020-10-06 4 LAMATTINA JOHN L IMNM Warrant (right to buy) C - Conversion D 9,00 11.111 11.111
2020-10-08 2020-10-06 4 LAMATTINA JOHN L IMNM Warrant (right to buy) C - Conversion D 9,00 -11.111 0
2020-10-08 2020-10-06 4 LAMATTINA JOHN L IMNM Series A Convertible Preferred Stock C - Conversion D -46.388 0
2020-10-08 2020-10-06 4 LAMATTINA JOHN L IMNM Common Stock C - Conversion D 46.388 46.388
2020-10-08 2020-10-06 4 Lefenfeld Michael IMNM Warrant (right to buy) C - Conversion D 9,00 11.111 11.111
2020-10-08 2020-10-06 4 Lefenfeld Michael IMNM Warrant (right to buy) C - Conversion D 9,00 -11.111 0
2020-10-08 2020-10-06 4 Lefenfeld Michael IMNM Series A Convertible Preferred Stock C - Conversion D -22.222 0
2020-10-08 2020-10-06 4 Lefenfeld Michael IMNM Common Stock C - Conversion D 22.222 22.222
2020-10-05 2020-10-01 4 Fitzgerald Richard F IMNM Employee Stock Option (right to buy) A - Award D 12,00 7.681 7.681
2020-10-05 2020-10-01 4 Fitzgerald Richard F IMNM Employee Stock Option (right to buy) A - Award D 12,00 104.802 104.802
2020-10-01 3 WAGENHEIM PHILIP IMNM Common Stock I 827.640
2020-10-01 3 WAGENHEIM PHILIP IMNM Common Stock I 166.666
2020-10-01 3 RAPP MICHAEL IMNM Common Stock I 827.640
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista